January 23, 2020

January 17, 2020

January 16, 2020

  • In 2019, the Texas State Legislature passed House Bill 2536 relating to drug cost transparency. It requires pharmaceutical drug manufacturers to report certain cost information on U.S. Food and Drug Administration-approved drugs sold in or into Texas.

January 15, 2020

January 14, 2020

January 7, 2020

January 2, 2020

Pages

Select a tag to filter news articles.